πŸ‡ΊπŸ‡Έ FDA
Patent

US 12227504

Spirocyclic compounds

granted A61PA61P35/00

Quick answer

US patent 12227504 (Spirocyclic compounds) held by C4 THERAPEUTICS, INC. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P35/00